comparemela.com

Latest Breaking News On - First light asset management - Page 15 : comparemela.com

SI-BONE, Inc (NASDAQ:SIBN) CFO Sells $30,483 47 in Stock

SI-BONE, Inc. (NASDAQ:SIBN – Get Free Report) CFO Anshul Maheshwari sold 1,733 shares of the firm’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $17.59, for a total transaction of $30,483.47. Following the transaction, the chief financial officer now directly owns 148,738 shares in the company, […]

Xenon Pharmaceuticals Inc (NASDAQ:XENE) Shares Acquired by Moran Wealth Management LLC

Moran Wealth Management LLC grew its stake in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 1.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 68,930 shares of the biopharmaceutical company’s stock after purchasing an additional 1,317 shares during the period. […]

Bicycle Therapeutics plc Forecasted to Earn FY2023 Earnings of ($5 24) Per Share (NASDAQ:BCYC)

Bicycle Therapeutics plc Forecasted to Earn FY2023 Earnings of ($5 24) Per Share (NASDAQ:BCYC)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Bioventus (BVS) to Release Quarterly Earnings on Tuesday

Bioventus (NYSE:BVS – Get Free Report) is set to announce its earnings results before the market opens on Tuesday, November 7th. Analysts expect the company to announce earnings of $0.06 per share for the quarter. Bioventus has set its FY 2023 guidance at -$0.24–$0.20 EPS.Investors that are interested in registering for the company’s conference call […]

Stifel Nicolaus Trims Health Catalyst (NASDAQ:HCAT) Target Price to $12 00

Health Catalyst (NASDAQ:HCAT – Free Report) had its target price cut by Stifel Nicolaus from $15.00 to $12.00 in a report issued on Wednesday, Benzinga reports. They currently have a hold rating on the stock. Several other equities research analysts have also issued reports on the company. Evercore ISI dropped their price target on Health […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.